JP2015506689A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506689A5
JP2015506689A5 JP2014554824A JP2014554824A JP2015506689A5 JP 2015506689 A5 JP2015506689 A5 JP 2015506689A5 JP 2014554824 A JP2014554824 A JP 2014554824A JP 2014554824 A JP2014554824 A JP 2014554824A JP 2015506689 A5 JP2015506689 A5 JP 2015506689A5
Authority
JP
Japan
Prior art keywords
gene
virus
expression vector
nucleotide sequence
viral expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014554824A
Other languages
English (en)
Japanese (ja)
Other versions
JP6228136B2 (ja
JP2015506689A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/022962 external-priority patent/WO2013112720A1/en
Publication of JP2015506689A publication Critical patent/JP2015506689A/ja
Publication of JP2015506689A5 publication Critical patent/JP2015506689A5/ja
Application granted granted Critical
Publication of JP6228136B2 publication Critical patent/JP6228136B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014554824A 2012-01-24 2013-01-24 パラインフルエンザウイルス５型ベースのワクチン Active JP6228136B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261590070P 2012-01-24 2012-01-24
US201261590056P 2012-01-24 2012-01-24
US61/590,056 2012-01-24
US61/590,070 2012-01-24
US201261683810P 2012-08-16 2012-08-16
US61/683,810 2012-08-16
PCT/US2013/022962 WO2013112720A1 (en) 2012-01-24 2013-01-24 Parainfluenza virus 5 based vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017198111A Division JP2018050624A (ja) 2012-01-24 2017-10-12 パラインフルエンザウイルス５型ベースのワクチン

Publications (3)

Publication Number Publication Date
JP2015506689A JP2015506689A (ja) 2015-03-05
JP2015506689A5 true JP2015506689A5 (enExample) 2016-03-10
JP6228136B2 JP6228136B2 (ja) 2017-11-08

Family

ID=48873896

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014554824A Active JP6228136B2 (ja) 2012-01-24 2013-01-24 パラインフルエンザウイルス５型ベースのワクチン
JP2017198111A Pending JP2018050624A (ja) 2012-01-24 2017-10-12 パラインフルエンザウイルス５型ベースのワクチン
JP2019168928A Active JP6900437B2 (ja) 2012-01-24 2019-09-18 パラインフルエンザウイルス５型ベースのワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017198111A Pending JP2018050624A (ja) 2012-01-24 2017-10-12 パラインフルエンザウイルス５型ベースのワクチン
JP2019168928A Active JP6900437B2 (ja) 2012-01-24 2019-09-18 パラインフルエンザウイルス５型ベースのワクチン

Country Status (13)

Country Link
US (6) US9732358B2 (enExample)
EP (2) EP2806891B1 (enExample)
JP (3) JP6228136B2 (enExample)
CN (2) CN104093422B (enExample)
AU (1) AU2013212097B2 (enExample)
BR (1) BR112014018179B1 (enExample)
CA (2) CA2860388C (enExample)
ES (1) ES2728248T3 (enExample)
MX (1) MX359638B (enExample)
MY (1) MY173638A (enExample)
PH (1) PH12014501255B1 (enExample)
PT (1) PT2806891T (enExample)
WO (2) WO2013112720A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9649371B2 (en) 2011-02-25 2017-05-16 University Of Georgia Research Foundation, Inc. Recombinant mumps virus vaccine
MY173638A (en) 2012-01-24 2020-02-12 Univ Georgia Parainfluenza virus 5 based vaccines
KR101577397B1 (ko) * 2014-01-15 2015-12-28 경북대학교 산학협력단 신규한 돼지 파라인플루엔자 바이러스 5(pPIV5), 이를 포함하는 백신 조성물 및 이를 이용한 돼지 파라인플루엔자 바이러스 검정 키트
WO2016176510A1 (en) 2015-04-28 2016-11-03 University Of Georgia Research Foundation, Inc. Piv5-based amplifying virus-like particles
JPWO2016199936A1 (ja) * 2015-06-12 2018-04-05 国立大学法人三重大学 ヒトパラインフルエンザ２型ウイルスベクター及びワクチン
CA3064897A1 (en) * 2017-05-25 2018-11-29 University Of Central Florida Research Foundation, Inc. Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells
RU2681473C1 (ru) * 2018-01-16 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" Тест-система для обнаружения генома вируса парагриппа 3 типа у крупного рогатого скота с помощью мультиплексной полимеразной цепной реакции с флуоресцентной детекцией в режиме реального времени
GB201816873D0 (en) * 2018-10-17 2018-11-28 Imperial Innovations Ltd Fusion protein
WO2020092207A1 (en) * 2018-10-28 2020-05-07 University Of Georgia Research Foundation Broadly reactive immunogens of influenza virus, compositions, and methods of use thereof
CL2018003869A1 (es) 2018-12-28 2021-01-15 Univ Pontificia Catolica Chile Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv
AU2021342576A1 (en) * 2020-09-21 2023-04-06 University Of Georgia Research Foundation, Inc. PIV5-based covid-19 vaccine
US20240102912A1 (en) * 2020-11-09 2024-03-28 Thrive Bioscience, Inc. Plaque counting assay method
CN113005149A (zh) * 2021-03-26 2021-06-22 中国农业大学 一种表达冠状病毒受体结合域串联二聚体的重组副流感病毒5型载体
CN118019854A (zh) * 2021-08-26 2024-05-10 乔治亚大学研究基金公司 J副粘病毒疫苗
AU2022347195A1 (en) * 2021-09-20 2024-05-02 Cyanvac Llc Piv5-based coronavirus vaccines and methods of use thereof
GB202209861D0 (en) * 2022-07-05 2022-08-17 Univ Court Univ St Andrews Viral vectors
CN120456918A (zh) * 2022-11-04 2025-08-08 蓝湖生物科技股份公司 重组rsv疫苗：制备和使用其的方法
CN121263205A (zh) * 2023-02-06 2026-01-02 塞维卡有限责任公司 修饰的piv5疫苗载体：制造方法和用途
CN116270766A (zh) * 2023-02-23 2023-06-23 天津理工大学 一种副流感病毒5型作为溶瘤病毒在抗肿瘤中的应用
CN117625560B (zh) * 2023-11-03 2025-09-16 中国农业大学 一种重组病毒rPIV5-H3及其制备方法、应用和疫苗

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638762B1 (en) 1994-11-28 2003-10-28 Genetic Therapy, Inc. Tissue-vectors specific replication and gene expression
CA2160038A1 (en) * 1995-07-14 1997-01-15 Biosignal Inc. Methods of screening compounds for their pharmacological relevance based on downregulation of recombinant receptors
AU2749297A (en) 1996-05-01 1997-11-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins
US6410023B1 (en) * 1997-05-23 2002-06-25 United States Of America Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
US5962274A (en) * 1998-03-13 1999-10-05 Wake Forest University Viral vector directed to predetermined target cells
EP1179054A2 (en) 1999-12-10 2002-02-13 The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens
US6764685B1 (en) 2000-03-21 2004-07-20 Medimmune Vaccines, Inc. Recombinant parainfluenza virus expression systems and vaccines
JP2002153278A (ja) 2000-11-22 2002-05-28 Hisamitsu Pharmaceut Co Inc ウイルスベクターの製造に用いられる細胞、その製法およびその細胞を用いたウイルスベクターの製造方法
US20050048030A1 (en) * 2001-09-28 2005-03-03 Raymond Pickles Paramyxoviruses as gene transfer vectors to lung cells
US7585667B2 (en) * 2003-06-13 2009-09-08 The United States Of America As Represented By The Department Of Health And Human Services Negative strand RNA virus replicon
PT2540312E (pt) * 2007-07-19 2015-08-31 Novavax Inc Vlps quiméricas de gripe aviária
US20090208495A1 (en) 2008-02-14 2009-08-20 Bayer Schering Pharma Ag Anti-tumor effective paramyxovirus
FR2938840B1 (fr) 2008-11-21 2010-12-17 Centre Nat Rech Scient Proteines mutantes de la proteine f de piv-5 et de piv-2
US10227569B2 (en) 2011-04-12 2019-03-12 Emory University Respiratory syncytial virus expression vectors
MY173638A (en) 2012-01-24 2020-02-12 Univ Georgia Parainfluenza virus 5 based vaccines

Similar Documents

Publication Publication Date Title
Imai et al. The role of receptor binding specificity in interspecies transmission of influenza viruses
Bouvier et al. The biology of influenza viruses
Cheung et al. Biology of influenza a virus
US8828406B2 (en) Influenza viruses and uses thereof
Neumann et al. Reverse genetics of influenza virus
Gambotto et al. Human infection with highly pathogenic H5N1 influenza virus
US9217157B2 (en) Recombinant influenza viruses and uses thereof
CA2631812C (en) Chimeric viruses presenting non-native surface proteins and uses thereof
JP5491173B2 (ja) イヌ細胞中でマイナス鎖ウイルスｒｎａを発現させるための方法および組成物
US20190125859A1 (en) Influenza virus vaccination regimens
Neumann et al. Generation of influenza A virus from cloned cDNAs—historical perspective and outlook for the new millenium
WO2008147496A2 (en) Neuraminidase-deficient live influenza vaccines
EP4048307A1 (en) Recombinant neuraminidase and uses thereof
Ye et al. Mutation from arginine to lysine at the position 189 of hemagglutinin contributes to the antigenic drift in H3N2 swine influenza viruses
Steel New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges
Ye et al. Influenza reverse genetics: dissecting immunity and pathogenesis
Hatta et al. Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection
An et al. Generation of highly productive and mammalian nonpathogenic recombinant H9N2 avian influenza viruses by optimization of 3’end promoter and NS genome
CN104704112A (zh) 传染性流感病毒的生产
Chang et al. Avian influenza virus: the threat of a pandemic
JP2017531032A (ja) ワクチン抗原の製造方法、得られるワクチン抗原、および使用
Finch et al. Design of alternative live attenuated influenza virus vaccines
Mara et al. Investigating the interaction between negative strand rna viruses and their hosts for enhanced vaccine development and production
Panahi et al. Characterization of nucleoprotein extracted from human influenza a virus cultured in two different cell lines
ZAHRA et al. Investigating the Influenza A Virus Proteins and Identifying the Role of Non-Structural Proteins of Ns1 And Ns2.